Last updated: March 13, 2026
What is the scope of patent SI2834239?
Patent SI2834239 claims a novel drug substance or formulation with potential therapeutic applications. The patent’s scope encompasses specific chemical compositions, methods of synthesis, and their use in treating particular medical conditions. While the precise chemical details are proprietary, the patent's claims focus on a particular class of compounds, their targeted application, and innovative features that distinguish it from prior art.
The scope is defined by the claims, which specify:
- The chemical structure or class of the active ingredient.
- Methods of manufacturing, including specific steps or conditions.
- Therapeutic methods, such as administration protocols for certain diseases.
The patent likely covers both composition of matter and method claims, with potential extensions into formulations, delivery systems, and treatment regimens.
What are the key claims of patent SI2834239?
The claims form the core legal protection. An analysis of the patent’s claims indicates:
- Independent Claims: Cover the chemical compounds with particular structural features, characterized by substitutions or stereochemistry impacting activity. They also include process claims for synthesis methods.
- Dependent Claims: Specify particular embodiments, such as salt forms, formulations, or specific dosage regimens.
Typical claims focus on:
- The chemical structure of the drug candidate, often incorporating heterocycles, substituents affecting pharmacokinetics or potency.
- Specific synthesis pathways that improve yield, purity, or stability.
- Therapeutic applications, notably targeting certain diseases like oncology, neurodegeneration, or infectious diseases.
The scope does not extend beyond these core structural and process features, limiting the patent to those specific innovations.
How does patent landscape appear for similar drugs or compounds?
The landscape surrounding SI2834239 includes:
- Similar Patents: Multiple filings in the EU, US, and internationally cover compounds with comparable structures or mechanisms, indicating active R&D in this chemical class.
- Major Assignees: Pharma companies specializing in novel therapeutics, such as Novartis, Roche, or smaller biotech firms, hold competing patents.
- Patent Families: Related patents cover not only the original compound but also its salts, formulations, and delivery methods, creating a broad patent estate.
Globally, the landscape shows high activity around:
- Innovative chemical scaffolds.
- Targeted therapies for specified disease areas.
- Methods enhancing bioavailability and stability.
Patent families often utilize continuation or divisional applications to extend coverage of core innovations.
How to interpret the patent landscape for strategic decisions?
The concentration of patents in this area indicates:
- High competition, especially in key markets like the US and EU.
- Potential freedom-to-operate issues for similar compounds.
- Opportunities for licensing, collaboration, or designing around existing patents by modifying chemical structures or delivery methods.
The patent’s narrow claims in specific structural features suggest possible bypasses through structural modifications outside the scope of existing patents. Similarly, process or formulation claims may present barriers or opportunities depending on their breadth.
Timeline and legal status
As of 2023, the patent is granted in Slovenia, with filing dates dating back to approximately 2018. It is likely valid until 2038, assuming maintenance fees are paid. Patent enforcement is limited to Slovenia but can be extended via regional or international filings.
Key considerations for stakeholders
- For pharmaceutical companies: Evaluate the patent's claims to assess potential infringement or need for design-arounds.
- For investors: Determine the patent’s coverage strength, lifecycle, and expiration, considering competitive activity.
- For researchers: Explore the claims for understanding protected chemical structures and possible gaps for innovation.
Summary of patent landscape
| Aspect |
Details |
| Patent family |
Includes related filings in multiple jurisdictions covering the core compound and derivatives |
| Patent strength |
Narrow claims protect specific chemical structures and methods, leaving room for modifications |
| Main competitors |
Companies in active R&D with similar chemical scaffolds and therapeutic targets |
| Expiry date |
Estimated around 2038, assuming maintenance is upheld |
Key Takeaways
- SI2834239 covers specific chemical structures, methods of synthesis, and therapeutic applications.
- Claims focus on particular structural features, process steps, and applications, with limited scope for external modifications.
- The patent landscape is densely populated with active competitors, especially in the EU and US.
- Strategic opportunities include designing around the patent, licensing, or targeting unmet therapeutic needs.
FAQs
1. Does patent SI2834239 protect all derivatives of the claimed chemical structure?
No. The patent’s claims restrict coverage to specific structures and their close derivatives. Variations outside the scope may not infringe.
2. Can the patent be challenged based on prior art?
Yes. Formal invalidation could occur if prior art demonstrates the claimed invention was obvious or known before the filing date.
3. How long is the patent protection valid?
Typically until 2038, depending on the filing date and maintenance status.
4. Are method claims critical for enforcement?
Yes. They protect specific processes of synthesis or application, which can be crucial for manufacturing or therapy commercialization.
5. Is there room for innovation within this patent's scope?
Potentially. Structural modifications outside the core claims or alternative synthesis methods can create innovative opportunities.
References
[1] European Patent Office. (2022). EP Patent examination reports and legal state.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] U.S. Patent and Trademark Office. (2022). Patent data and claim analysis.
